NewsBenzinga氙制药宣布自愿暂停进行中的精神病学研究的新患者招募,因出现神经精神不良事件;目前正在进行的研究中已招募的患者仍在进行治疗。 氙制药宣布自愿暂停进行中的精神病学研究的新患者招募,因出现神经精神不良事件;目前正在进行的研究中已招募的患者仍在进行治疗。 Benzinga 2026.09.17 20:05 (GMT+0) Open on Benzinga Other news Nvidia China Trouble Could Spill Over to These AI Chip Stocks Trump says ex-Nvidia CEO Jensen Huang’s affair with an alleged Chinese spy did not threaten national security Tiger Global Management Takes New Stake In Ferrari N V With 602,700 Shares Citigroup Maintains Neutral on EOG Resources, Raises Price Target to $155 Citigroup Maintains Neutral on Rivian Automotive, Lowers Price Target to $14.5 Trump Backs Jensen Huang’s Return to Nvidia as Sam Altman Says 'Heroes Have Flaws'
Trump says ex-Nvidia CEO Jensen Huang’s affair with an alleged Chinese spy did not threaten national security